Zobrazeno 1 - 10 of 146 pro vyhledávání: '"NIAID AIDS Vaccine Clinical Trials Network"'
1
V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network
Autor: D C Montefiori, B S Graham, J Zhou, R A Bucco, D H Schwartz, L A Cavacini, M R Posner
Publikováno v: Journal of Clinical Investigation. 92:840-847
Sera from 11 volunteers immunized with a recombinant HIV-1 gp160-expressing vaccinia virus (HIVAC-1e; Oncogen/Bristol-Myers Squibb, Seattle, WA) and boosted with baculovirus-derived rgp160 (VaxSyn; MicroGeneSys, Inc., Meriden, CT) were evaluated for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a850e63fa94b70cd4e2825685d07b2df
https://doi.org/10.1172/jci116658
Zobrazit plný text záznamu
2
Akademický článek
Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein. NIAID AIDS Vaccine Clinical Trials Network.
Autor: Gorse GJ; Division of Infectious Diseases, St. Louis University Health Sciences Center, MO 63110-0250, USA., Patel GB, Newman FK, Mandava M, Belshe RB
Publikováno v: Vaccine [Vaccine] 1995 Sep; Vol. 13 (13), pp. 1170-9.
Zobrazit plný text záznamu
3
Akademický článek
HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network.
Autor: Gorse GJ; Division of Infectious Diseases, Saint Louis University Health Sciences Center, MO 63110-0250, USA., Rogers JH, Perry JE, Newman FK, Frey SE, Patel GB, Belshe RB
Publikováno v: Vaccine [Vaccine] 1995 Feb; Vol. 13 (2), pp. 209-14.
Zobrazit plný text záznamu
4
Akademický článek
HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network.
Autor: Gorse GJ; Department of Internal Medicine, Saint Louis University School of Medicine, MO., Schwartz DH, Graham BS, Matthews TJ, Stablein DM, Frey SE, Belshe RB, Clements ML, Wright PF, Eibl M, et. al.
Publikováno v: Clinical and experimental immunology [Clin Exp Immunol] 1994 Nov; Vol. 98 (2), pp. 178-84.
Zobrazit plný text záznamu
5
Akademický článek
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.
Autor: Belshe RB; Department of Medicine, St Louis University School of Medicine, MO 63104., Graham BS, Keefer MC, Gorse GJ, Wright P, Dolin R, Matthews T, Weinhold K, Bolognesi DP, Sposto R, et. al.
Publikováno v: JAMA [JAMA] 1994 Aug 10; Vol. 272 (6), pp. 475-80.
Zobrazit plný text záznamu
6
Akademický článek
Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network.
Autor: Gorse GJ; Division of Infectious Diseases and Immunology, Saint Louis University School of Medicine, MO 63104., Frey SE, Patel G, Newman FK, Belshe RB
Publikováno v: Vaccine [Vaccine] 1994 Aug; Vol. 12 (10), pp. 912-8.
Zobrazit plný text záznamu
7
Akademický článek
Safety profile of HIV vaccination: first 1000 volunteers of AIDS vaccine evaluation group. NIAID AIDS Vaccine Clinical Trials Network.
Autor: Keefer MC; University of Rochester School of Medicine and Dentistry, NY., Belshe R, Graham B, McElrath J, Clements ML, Sposto R, Fast P
Publikováno v: AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 1994; Vol. 10 Suppl 2, pp. S139-40.
Zobrazit plný text záznamu
8
Akademický článek
V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
Autor: Montefiori DC; Department of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232., Graham BS, Zhou J, Zhou J, Bucco RA, Schwartz DH, Cavacini LA, Posner MR
Publikováno v: The Journal of clinical investigation [J Clin Invest] 1993 Aug; Vol. 92 (2), pp. 840-7.
Zobrazit plný text záznamu
9
Akademický článek
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network.
Autor: Graham BS; Dept. of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232., Matthews TJ, Belshe RB, Clements ML, Dolin R, Wright PF, Gorse GJ, Schwartz DH, Keefer MC, Bolognesi DP, et. al.
Publikováno v: The Journal of infectious diseases [J Infect Dis] 1993 Mar; Vol. 167 (3), pp. 533-7.
Zobrazit plný text záznamu
10
Akademický článek
Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network.
Autor: Montefiori DC; Department of Pathology, Vanderbilt University Medical School, Nashville, Tennessee 37232., Graham BS, Kliks S, Wright PF
Publikováno v: Journal of clinical immunology [J Clin Immunol] 1992 Nov; Vol. 12 (6), pp. 429-39.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje